Literature DB >> 10699318

Drug delivery to mitochondria: the key to mitochondrial medicine.

M P Murphy1, R A Smith.   

Abstract

The major function of mitochondria in human cells is to provide ATP by oxidative phosphorylation. However, mitochondria have many other roles including the modulation of intracellular calcium concentration and the regulation of apoptotic cell death. Furthermore, the mitochondrial respiratory chain is a major source of damaging free radicals. Consequently, mitochondrial dysfunction contributes to a number of human diseases, ranging from neurodegenerative diseases and ischaemia-reperfusion injury to obesity and diabetes. In addition, mutations to nuclear or mitochondrial DNA cause a number of human diseases. Therefore, strategies to prevent mitochondrial damage or to manipulate mitochondrial function in clinically useful ways may provide new therapies for a range of human disorders. Here we outline why mitochondria are a potentially important target for drug delivery and discuss how to deliver bioactive molecules selectively to mitochondria within cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699318     DOI: 10.1016/s0169-409x(99)00069-1

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  101 in total

1.  Design and evaluation of multifunctional nanocarriers for selective delivery of coenzyme Q10 to mitochondria.

Authors:  Anjali Sharma; Ghareb M Soliman; Noura Al-Hajaj; Rishi Sharma; Dusica Maysinger; Ashok Kakkar
Journal:  Biomacromolecules       Date:  2011-12-16       Impact factor: 6.988

Review 2.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

Review 3.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

4.  Therapeutic targeting of mitochondrial superoxide in hypertension.

Authors:  Anna E Dikalova; Alfiya T Bikineyeva; Klaudia Budzyn; Rafal R Nazarewicz; Louise McCann; William Lewis; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

5.  Downregulation of IDH2 exacerbates H2O2-mediated cell death and hypertrophy.

Authors:  Hyeong Jun Ku; Jeen-Woo Park
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

6.  Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential.

Authors:  Swanand Patil; Amanda Sandberg; Eric Heckert; William Self; Sudipta Seal
Journal:  Biomaterials       Date:  2007-08-01       Impact factor: 12.479

7.  Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease.

Authors:  A Muratovska; R N Lightowlers; R W Taylor; D M Turnbull; R A Smith; J A Wilce; S W Martin; M P Murphy
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

8.  DNA mismatch binding and antiproliferative activity of rhodium metalloinsertors.

Authors:  Russell J Ernst; Hang Song; Jacqueline K Barton
Journal:  J Am Chem Soc       Date:  2009-02-18       Impact factor: 15.419

9.  The mitochondrial antioxidants MitoE(2) and MitoQ(10) increase mitochondrial Ca(2+) load upon cell stimulation by inhibiting Ca(2+) efflux from the organelle.

Authors:  Sara Leo; György Szabadkai; Rosario Rizzuto
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 10.  NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?

Authors:  Evan A Bordt; Brian M Polster
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.